financetom
Business
financetom
/
Business
/
FDA Sets PDUFA Goal Date for Lexicon Pharmaceuticals' NDA Resubmission for Sotagliflozin
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FDA Sets PDUFA Goal Date for Lexicon Pharmaceuticals' NDA Resubmission for Sotagliflozin
Jul 16, 2024 6:20 AM

08:51 AM EDT, 07/16/2024 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) said Tuesday the US Food and Drug Administration has set a Prescription Drug User Fee Act goal date of Dec. 20 for Zynquista as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease.

The company said the FDA indicated that it considers the resubmission to be a complete response to the regulator's action letter in 2019 regarding the sotagliflozin NDA for type 1 diabetes.

"With a PDUFA date now in hand, we can begin the next phase of launch preparation for Zynquista," Chief Executive Mike Exton said in a statement.

Price: 2.0700, Change: -0.05, Percent Change: -2.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RPM International's Fiscal Q2 Adjused Earnings, Net Sales Increase
RPM International's Fiscal Q2 Adjused Earnings, Net Sales Increase
Jan 7, 2025
07:02 AM EST, 01/07/2025 (MT Newswires) -- RPM International ( RPM ) reported fiscal Q2 adjusted earnings Tuesday of $1.39 per diluted share, up from $1.22 a year earlier. Analysts polled by FactSet expected $1.34. Net sales for the quarter ended Nov. 30 were $1.85 billion, up from $1.79 billion a year earlier. Analysts surveyed by FactSet expected $1.79 billion....
Lindsay's Fiscal Q1 Earnings, Revenue Increase
Lindsay's Fiscal Q1 Earnings, Revenue Increase
Jan 7, 2025
07:03 AM EST, 01/07/2025 (MT Newswires) -- Lindsay (LNN) reported fiscal Q1 earnings Tuesday of $1.57 per diluted share, up from $1.36 a year earlier. Three analysts surveyed by FactSet expected $1.33. Revenue for the quarter ended Nov. 30 was $166.3 million, compared with $161.4 million a year earlier. Four analysts surveyed by FactSet expected $169.8 million. ...
Oil services provider Flowco seeks up to $2 bln valuation in US IPO
Oil services provider Flowco seeks up to $2 bln valuation in US IPO
Jan 7, 2025
Jan 7 (Reuters) - Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its initial public offering in the United States. The company said it would sell 17.8 million shares at a price range of $21 to $23 per share, potentially fetching up to $409.4 million if priced at the...
Oil services provider Flowco seeks up to $2 billion valuation in US IPO
Oil services provider Flowco seeks up to $2 billion valuation in US IPO
Jan 7, 2025
(Reuters) - Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its initial public offering in the United States. The company said it would sell 17.8 million shares at a price range of $21 to $23 per share, potentially fetching up to $409.4 million if priced at the upper limit....
Copyright 2023-2026 - www.financetom.com All Rights Reserved